0	5	NF-X2	nf-x2	NN
6	10	that	that	WDT
11	16	binds	bind	VBZ
17	19	to	to	TO
20	23	the	the	DT
24	27	DRA	DRA	NNP
28	34	X2-box	X2-box	NNP
35	37	is	be	VBZ
38	47	activator	activator	NN
48	55	protein	protein	NN
56	57	1	1	CD
57	58	.	.	.

59	69	Expression	expression	NN
70	77	cloning	cloning	NN
78	80	of	of	IN
81	86	c-Jun	c-jun	NN
86	87	.	.	.

89	94	Human	human	JJ
95	100	class	class	NN
101	103	II	ii	CD
104	107	MHC	MHC	NNP
108	110	Ag	Ag	NNP
111	114	are	be	VBP
115	116	a	a	DT
117	123	family	family	NN
124	126	of	of	IN
127	131	cell	cell	NN
132	139	surface	surface	NN
140	153	glycoproteins	glycoprotein	NNS
153	154	.	.	.

155	160	Their	their	PRP$
161	173	constitutive	constitutive	JJ
174	184	expression	expression	NN
185	187	is	be	VBZ
188	195	limited	limit	VBN
196	198	to	to	TO
199	200	B	B	NNP
201	212	lymphocytes	lymphocyte	NNS
213	216	and	and	CC
217	223	thymic	thymic	JJ
224	234	epithelial	epithelial	JJ
235	240	cells	cell	NNS
240	241	.	.	.

242	244	In	in	IN
245	249	many	many	JJ
250	255	other	other	JJ
256	261	cells	cell	NNS
262	267	their	their	PRP$
268	278	expression	expression	NN
279	282	can	can	MD
283	285	be	be	VB
286	293	induced	induce	VBN
294	296	by	by	IN
297	306	IFN-gamma	IFN-gamma	NNP
306	307	.	.	.

308	317	Conserved	conserve	VBN
318	326	upstream	upstream	JJ
327	335	promoter	promoter	NN
336	345	sequences	sequence	NNS
346	354	regulate	regulate	VBP
355	359	this	this	DT
360	375	tissue-specific	tissue-specific	JJ
376	386	expression	expression	NN
387	389	of	of	IN
390	395	class	class	NN
396	398	II	ii	CD
399	404	genes	gene	NNS
404	405	.	.	.

406	408	In	in	IN
409	412	the	the	DT
413	416	DRA	DRA	NNP
417	425	promoter	promoter	NN
425	426	,	,	,
427	430	one	one	CD
431	433	of	of	IN
434	439	these	these	DT
440	450	cis-acting	cis-acting	JJ
451	461	regulatory	regulatory	JJ
462	468	motifs	motif	NNS
469	471	is	be	VBZ
472	475	the	the	DT
476	482	X2-box	x2-box	NN
483	485	to	to	TO
486	491	which	which	WDT
492	499	nuclear	nuclear	JJ
500	506	factor	factor	NN
507	509	X2	x2	NN
510	511	(	(	(
511	516	NF-X2	nf-x2	NN
516	517	)	)	)
518	523	binds	bind	VBZ
523	524	.	.	.

525	529	Here	here	RB
529	530	,	,	,
531	533	we	we	PRP
534	541	present	present	VBP
542	545	the	the	DT
546	555	isolation	isolation	NN
556	559	and	and	CC
560	576	characterization	characterization	NN
577	579	of	of	IN
580	583	the	the	DT
584	595	full-length	full-length	JJ
596	600	cDNA	cdna	NN
601	606	clone	clone	NN
607	615	encoding	encode	VBG
616	621	NF-X2	nf-x2	NN
621	622	.	.	.

623	627	This	this	DT
628	632	cDNA	cdna	NN
633	638	clone	clone	NN
639	642	was	be	VBD
643	651	isolated	isolate	VBN
652	654	by	by	IN
655	665	expression	expression	NN
666	670	cDNA	cdna	NN
671	678	cloning	cloning	NN
678	679	,	,	,
680	683	and	and	CC
684	691	encodes	encode	VBZ
692	695	the	the	DT
696	701	human	human	JJ
702	707	c-Jun	c-jun	NN
708	715	protein	protein	NN
715	716	,	,	,
717	722	which	which	WDT
723	731	together	together	RB
732	736	with	with	IN
737	742	c-Fos	c-fos	NN
743	748	forms	form	VBZ
749	752	the	the	DT
753	766	heterodimeric	heterodimeric	JJ
767	776	activator	activator	NN
777	786	protein-1	protein-1	NN
787	800	transcription	transcription	NN
801	808	complex	complex	NN
808	809	.	.	.

810	817	Whereas	whereas	IN
818	829	c-Fos/c-Jun	c-fos/c-jun	NN
830	842	heterodimers	heterodimer	NNS
843	845	do	do	VBP
846	849	not	not	RB
850	855	exist	exist	VB
856	858	in	in	IN
859	860	B	B	NNP
861	866	cells	cell	NNS
866	867	,	,	,
868	872	they	they	PRP
873	877	form	form	VBP
878	881	and	and	CC
882	886	bind	bind	VBP
887	889	to	to	TO
890	893	the	the	DT
894	900	X2-box	x2-box	NN
901	903	in	in	IN
904	909	class	class	NN
910	912	II	ii	CD
913	926	nonexpressing	nonexpressing	JJ
927	932	cells	cell	NNS
932	933	.	.	.

934	938	Thus	thus	RB
938	939	,	,	,
940	951	c-Fos/c-Jun	c-fos/c-jun	NN
952	964	heterodimers	heterodimer	NNS
965	970	might	might	MD
971	981	contribute	contribute	VB
982	984	to	to	TO
985	988	the	the	DT
989	999	repression	repression	NN
1000	1002	of	of	IN
1003	1006	DRA	DRA	NNP
1007	1011	gene	gene	NN
1012	1022	expression	expression	NN
1022	1023	.	.	.